Preferred Label : tezepelumab;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3479050/fr/tezspire-tezepelumab-asthme
2023
France
evaluation of the transparency committee
asthma
Asthma
tezepelumab
tezepelumab
tezspire
asthma
Tezepelumab
Asthma Pathway
asthma, nos

---
https://www.has-sante.fr/jcms/p_3333360/fr/tezepelumab-tezepelumab
https://www.has-sante.fr/jcms/p_3333427/fr/decision-n-2022-0128/dc/sem-du-14-avril-2022-du-college-de-la-haute-autorite-de-sante-portant-refus-de-la-demande-d-autorisation-d-acces-precoce-de-la-specialite-tezepelumab
2022
false
false
false
France
evaluation of the transparency committee
tezepelumab
tezepelumab

---
https://www.has-sante.fr/jcms/p_3398479/fr/tezspire-tezepelumab-asthme
2022
false
false
false
France
adult
adolescent
evaluation of the transparency committee
asthma
tezepelumab

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.